Favorable outcomes of DDX41-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide

被引：2
|
作者：
Tiong, Ing S. [1 ,2 ,3 ]
Stevenson, William S. [4 ,5 ]
Wall, Meaghan [3 ,6 ]
Yap, Yan Zhuang [1 ]
Seymour, John F. [1 ,7 ,8 ]
Kenealy, Melita [3 ,9 ]
Blombery, Piers [1 ,7 ,8 ]
机构：
[1] Peter MacCallum Canc Ctr, 300 Grattan St, Melbourne, Vic 3000, Australia
[2] Alfred Hosp, Melbourne, Vic, Australia
[3] Monash Univ, Melbourne, Vic, Australia
[4] Royal North Shore Hosp, St Leonards, NSW, Australia
[5] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia
[6] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Melbourne, Vic, Australia
[7] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[8] Royal Melbourne Hosp, Melbourne, Vic, Australia
[9] Cabrini Hlth, Melbourne, Vic, Australia
来源：
EJHAEM | 2023年 / 4卷 / 04期
关键词：
RISK; DDX41;
D O I：
10.1002/jha2.767
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1212 / 1215
页数：4
相关论文
共 50 条
  • [21] MONITORING OF THE CYTOGENETIC ALTERATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE
    De Gusmao, B.
    Campeny, A.
    Perez-Persona, E.
    Oiartzabal, I.
    Ardanaz, M.
    Menchaca, M.
    Mendizabal, A.
    Wong, J.
    Pereda, A.
    de Castro, J.
    HAEMATOLOGICA, 2013, 98 : 582 - 583
  • [22] Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
    Platzbecker, U.
    Germing, U.
    LEUKEMIA, 2013, 27 (09) : 1813 - 1819
  • [23] IMPACT OF COMORBIDITIES ON OVERALL SURVIVAL IN THE ELDERLY WITH MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA TREATED BY AZACITIDINE
    Brechemier, D.
    Bertoli, S.
    Comont, T.
    Balardy, L.
    Recher, C.
    Lauwers-Cances, V.
    Beyne-Rauzy, O.
    LEUKEMIA RESEARCH, 2015, 39 : S47 - S48
  • [24] An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia
    Solly, Francoise
    Koering, Catherine
    Mohamed, Aminetou Mint
    Maucort-Boulch, Delphine
    Robert, Guillaume
    Auberger, Patrick
    Flandrin-Gresta, Pascale
    Ades, Lionel
    Fenaux, Pierre
    Kosmider, Olivier
    Tavernier-Tardy, Emmanuelle
    Cornillon, Jerome
    Guyotat, Denis
    Campos, Lydia
    Mortreux, Franck
    Wattel, Eric
    CLINICAL CANCER RESEARCH, 2017, 23 (12) : 3025 - 3034
  • [25] Successful management of acute graft-versus-host disease with ibrutinib during cord blood transplantation for germline DDX41-mutated acute myeloid leukemia
    Uchimura, Ayana
    Yasuda, Hajime
    Onagi, Hiroko
    Inano, Tadaaki
    Shirane, Shuichi
    Ishii, Midori
    Azusawa, Yoko
    Hamano, Yasuharu
    Eguchi, Hidetaka
    Arai, Masami
    Ando, Jun
    Ando, Miki
    HELIYON, 2024, 10 (02)
  • [26] Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia
    Voso, Maria Teresa
    Niscola, Pasquale
    Piciocchi, Alfonso
    Fianchi, Luana
    Maurillo, Luca
    Musto, Pellegrino
    Pagano, Livio
    Mansueto, Giovanna
    Criscuolo, Marianna
    Aloe-Spiriti, Maria Antonietta
    Buccisano, Francesco
    Venditti, Adriano
    Tendas, Andrea
    Piccioni, Anna Lina
    Zini, Gina
    Latagliata, Roberto
    Filardi, Nunzio
    Fragasso, Alberto
    Fenu, Susanna
    Breccia, Massimo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (04) : 344 - 351
  • [27] Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Cluzeau, Thomas
    Furstoss, Nathan
    Savy, Coline
    El Manaa, Wejdane
    Zerhouni, Marwa
    Blot, Lauriane
    Calleja, Anne
    Dufies, Maeva
    Dubois, Alix
    Ginet, Clemence
    Mounier, Nicolas
    Garnier, Georges
    Raynaud, Sophie
    Rohrlich, Pierre Simon
    Peterlin, Pierre
    Stamatoullas, Aspasia
    Chermat, Fatiha
    Fenaux, Pierre
    Jacquel, Arnaud
    Robert, Guillaume
    Auberger, Patrick
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [28] DDX41 mutation in Patients with Idiopathic Cytopenia of Undetermined Significance, Myelodysplastic Syndrome, and Acute Myeloid Leukemia
    Choi, Eun-Ji
    Cho, Young-Uk
    Jang, Seongsoo
    Park, Chan-jeoung
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Kyoo Hyung
    Hur, Eun-Hye
    Kim, Nayoung
    Ouk, Hee Jeong
    Lee, Je-Hwan
    BLOOD, 2019, 134
  • [29] DECITABINE AS THERAPY FOR A PATIENT WITH ACUTE MYELOID LEUKEMIA SECONDARY TO MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE: A CASE REPORT
    Guaragna, G.
    Rinaldi, E.
    Spina, A.
    Mele, G.
    Quarta, G.
    Melpignano, A.
    HAEMATOLOGICA, 2017, 102 : 159 - 159
  • [30] INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA TREATED WITH AZACITIDINE: REPORT FROM A SINGLE CENTER
    Quinto, A. M.
    De March, E.
    Castelli, M.
    Binotto, G.
    Semenzato, G.
    Adami, F.
    HAEMATOLOGICA, 2015, 100 : 471 - 472
12345